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Introduction: This study aimed to determine if beneficial effects of individualized feedback 
of fracture risk on osteoporosis preventive behaviors and bone mineral density observed in a 
2-year trial were sustained long-term. 
Methods: This was a 10-year follow-up of a 2-year RCT in 470 premenopausal women aged 
25–44 years, who were randomized to one of two educational interventions (the Osteoporosis 
Prevention and Self-management course [OPSMC] or an osteoporosis information leaflet) 
and received tailored feedback of their relative risk of fracture in later life (high versus 
normal risk groups). Bone mineral density of lumbar spine and femoral neck measured by 
dual-energy X-ray absorptiometry. Physical activity, dietary calcium intake, calcium and 
vitamin D supplements, and smoking status measured by questionnaires. 
Results: From 2 to 12 years, the high-risk group had a smaller decrease in femoral neck bone 
mineral density (β=0.023, 95% CI=0.005, 0.041 g/cm2) but similar lumbar spine bone 
mineral density change as the normal risk group. They were more likely to use calcium 
(relative risk=1.66, 95% CI=1.22, 2.24) and vitamin D supplements (1.99, 95% CI=1.27, 
3.11). The OPSMC had no effects on bone mineral density change. Both high risk (versus 
normal risk) and the OPSMC groups (versus leaflet) had a more favorable pattern of smoking 
behavior change (relative risk=1.85, 95% CI=0.70, 4.89 and relative risk=2.27, 95% CI=0.86, 
6.01 for smoking cessation; relative risk=0.33, 95% CI=0.13, 0.80 and relative risk=0.28, 
95% CI=0.10, 0.79 for commenced or persistent smoking). 
Conclusions: Feedback of high fracture risk to younger women was associated with long-
term improvements in osteoporosis preventive behaviors and attenuated femoral neck bone 
mineral density loss therefore this could be considered as a strategy to prevent osteoporosis. 
Trial registration: Australian New Zealand Clinical Trials Registry (ANZCTR) 
NCT00273260. 
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INTRODUCTION 
Chronic diseases are the leading preventable causes of premature death and disability and 
lifestyle factors, such as good nutrition and physical activity, are critical for their prevention.1 
Assessment of health risks with feedback is a common and useful approach2–4 for improving 
health behaviors. For example, there is strong evidence that risk feedback with health 
education can improve many health behaviors in the workplace including tobacco use, 
alcohol consumption, and dietary fat intake.5 The commonality of lifestyle risk factors across 
chronic diseases means that a risk feedback intervention for one disease that improves 
lifestyle behaviors is likely to have benefits for a range of conditions. 
 
Individualized risk feedback has been applied to the prevention of osteoporosis and related 
fractures.6 Previous controlled trials suggest that premenopausal women informed of having 
low bone mineral density (BMD) or higher fracture risk improve osteoporosis preventive 
behaviors (e.g., cigarette smoking, low levels of physical activity, inadequate calcium intake, 
and vitamin D deficiency).7–9 For example, in a previous 2-year RCT premenopausal women 
receiving feedback of being at high fracture risk in later life had more favorable changes in 
preventive behaviors and greater increases in femoral neck (FN) BMD compared with those 
who were informed they had normal risk.7 However, to the authors’ knowledge, there are no 
published trials examining the long-term effects of providing individualized risk feedback for 
fracture or any other diseases. Long-term effectiveness is important for diseases that develop 
slowly and become apparent later in life, such as osteoporosis and cardiovascular disease. 
 
Therefore, the aim of this study is to perform a further 10-year follow-up of a previous 2-year 
RCT to examine the long-term effects of the feedback of fracture risk and educational 
interventions on BMD of FN and lumbar spine (LS) and osteoporosis preventive behaviors. 
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METHODS 
Study Sample 
This was an additional 10-year follow-up of a registered (NCT00273260) 2-year RCT 
previously conducted in Southern Tasmania, Australia.7 Women aged 25–44 years were 
randomly selected from the 2000 Tasmanian Electoral Roll and recruited between April and 
November 2000 from this predominantly Caucasian population.7 Women were excluded if 
they had previous measurement of BMD, thyroid disease, renal failure, malignancy, 
rheumatoid arthritis, a history of hysterectomy or were taking hormone replacement 
therapies, were pregnant or planning pregnancy within 2 years, or were lactating. Ethics 
approval was obtained from the Tasmania Health and Medical Human Research Ethics 
Committee. All participants gave written informed consent. 
 
Measures 
At baseline, 470 women were randomized 1:1 to receive one of two osteoporosis educational 
interventions: the Osteoporosis Prevention and Self-management course (OPSMC) (OPSMC 
group, n=219) or an information leaflet (leaflet group, n=251) using computer generated 
random numbers. The OPSMC is a chronic disease self-management course developed by the 
Arthritis Foundation of Victoria and utilized by Osteoporosis Australia, aiming to increase 
knowledge and improve confidence and awareness and self-management of osteoporosis 
prevention. It emphasizes lifestyle changes such as increasing calcium intake and appropriate 
physical activity. OPSMC sessions of 2 hours were held weekly for 4 weeks (≤16 participants 
per group). The osteoporosis information leaflet from Osteoporosis Australia, 
“Understanding Osteoporosis,” provided a comprehensive description of osteoporosis and of 
the role of lifestyle factors including diet, exercise, smoking, and optimal levels of calcium 
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intake and exercise.8 This was delivered by mail and did not include the intensive behavioral 
change interventions provided during the OPSMC. 
 
Spine and hip BMD was measured at baseline, 2, and 12 years by operators blinded to 
intervention status by dual-energy X-ray absorptiometry (Hologic QDR2000 densitometer), 
which was calibrated daily (Coefficient Of Variation=1%). At baseline, those with a mean 
spine and hip T-score<0 were informed that they were at a higher risk of fracture in later life 
(high-risk group, n=232) whereas those with a mean T-score≥0 were informed that they were 
not at higher risk (normal risk group, n=238). This was based on the observation that those in 
the lower half of the BMD distribution have threefold higher fracture risk both in later life 
and in the early postmenopausal period.10 The leaflet group received written feedback of 
fracture risk with their leaflet by mail, and the OPSMC group received written feedback at 
the first OPSMC session. Participants at higher risk were asked to discuss their BMD results 
with general practitioners. 
 
Primary outcomes for the 12-year follow-up were FN and LS BMD, calcium intake, calcium 
supplement use, and physical activity. These behaviors were measured yearly for first 2 years 
and at 12 years. Secondary outcomes were use of vitamin D supplements and smoking status. 
 
Calcium intake was assessed by a validated short food frequency questionnaire, which 
correlates well with 4 day weighed records for estimated calcium intake (r =0.79, p=0.001).11 
The calcium content of food was determined by Australian food composition tables.12 
Participants were classified as taking calcium supplements if they reported taking a 
supplement containing calcium alone or as a main ingredient at a frequency of four or more 
times weekly. 
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Physical activity was assessed by a questionnaire validated in American adolescents,13 
modified for Tasmanian conditions and previously in women of this age.14 This asked how 
many days in the last 14 the participants performed >20 minutes of strenuous exercise and 
light exercise, measured in five categories (0, 1–2, 3–5, 6–8, and ≥9 days). Smoking status 
was assessed by questionnaire asking whether participants were regular smokers, defined as 
smoking at least seven cigarettes, cigars, or pipes weekly for >3 months. 
 
Changes in osteoporosis preventive behaviors were determined by their status at 2 and 12 
years. Participants who smoked at 2 but not 12 years were classified as ceased smoking, those 
who did not smoke at either 2 or 12 years as never smoking, those who did not smoke at 2 
years but did at 12 years as commenced smoking, and as persistent smoking otherwise. A 
similar classification was used for change in calcium supplement use. Change in calcium 
intake was categorized as increased or decreased and change in physical activity was 
classified as unchanged, increased or decreased. 
 
At 12 years, participants were asked if they had regularly (five or more times/week for >9 
months of the year) used vitamin D supplement during each year during the last 12 years. 
Participants were categorized as recent users if using vitamin D supplements for the 
preceding 2 consecutive years and no recent use otherwise. 
 
Serum 25-hydroxyvitamin D (25(OH)D) level was assessed at 12 years, from venous blood 
samples, using liquid chromatography tandem-mass spectrometry (CV=3%–6%, using an 
internal standard). 
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Other factors measured at baseline, 2 and 12 years included height by stadiometer (The 
Leicester height measure) and weight by a single set of calibrated scales (Heine). BMI was 
calculated [weight/height2 (kg/m2)]. Breastfeeding history, education level, employment 
status, and marital status were assessed by questionnaire. Self-reported fractures with age at 
each fracture, use of anti-osteoporosis medications, and menopausal status was also reported 
at 12 years. 
 
Statistical Analysis 
Mean (SD), median (IQR), and number (%) were used to describe continuous and categoric 
variables as appropriate (based on normality checking using Shapiro–Wilk test). Differences 
in characteristics between intervention groups were tested using Student’s t-test, Kruskal–
Wallis or chi-square test as appropriate. Linear mixed-effects modeling was used to estimate 
effects of fracture risk feedback and educational interventions on changes in FN and LS 
BMD from 2 to 12 years, adjusting for potential confounders. Intervention groups, time 
(follow-up number) and the interaction between the interventions X time (treatment effect) 
were considered fixed factors in the model. Potential interactions between the two 
interventions were also tested. Participant identification number was included as a random 
effect to account for the dependence of repeated observations. This model is powerful in 
dealing with repeated measures with missing data.15 Log-binomial and log-multinomial 
regressions were used to estimate the relative risk (RR) of categories of behavior change, 
from 2 to 12 years, associated with each intervention. This model is very well suited to 
compute an adjusted RR in clinical trials of common outcomes.16 Models were further 
adjusted for age, anthropomorphic and sociodemographic factors, and menopausal status at 
the 12 year follow-up. Confounders were selected if (1) the association with both the 
outcome and exposure of interest was biologically plausible, and (2) their addition to the 
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model caused a >10% change in the estimated coefficient for the intervention. To handle 
missing data, including that missing because of loss to follow-up, a weighted estimating 
equation method was used.17,18 Analyses were performed in Stata, version 12. A two-tailed p-
value <0.05 was considered statistically significant. 
 
RESULTS 
A total of 470 women (64% response rate) aged 25–44 years were recruited at baseline with 
88% (n=415) retained at year 2 and 74% (n=347) at year 12 (Figure 1). Women who 
completed 12-year follow-up had similar characteristics to those who were lost to follow-up, 
other than being slightly older (Appendix Table 1). Women in the high-risk group were 
shorter and had lower weight; there was a greater proportion of women who had ever smoked 
among those who received the information leaflet than among those who received the 
OPSMC (Table 1). Menopausal status at 12 years was similar across the groups as were other 
baseline characteristics. Serum 25(OH)D at 12 years was slightly higher in the high-risk 
group than the normal risk group but was similar between educational intervention groups. 
Five participants used anti-osteoporosis medication and they were all in the OPSMC and 
high-risk groups. 
 
Unadjusted FN and LS BMD at each time point (stratified by intervention groups) and the 
estimated effects of the interventions over time are shown in Appendix Table 2 and Table 2, 
respectively. There were no significant interactions between educational intervention X 
fracture risk feedback. FN and LS BMD were lower at 12 years than at 2 years in both 
fracture risk feedback and both educational intervention groups as well as in the study sample 
as a whole (p<0.001 for all). Women in the high-risk group had a smaller reduction in FN 
BMD between 2 and 12 years than the normal risk group after adjusting for confounders 
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(β=0.023, 95% CI=0.005, 0.041). There was no evidence for a similar effect for LS BMD. 
There were no effects of educational intervention on change in BMD at any site. 
 
Table 3 gives the estimated RR of each behavior change category between intervention 
groups. Women in the high-risk group (versus normal risk) were more likely to have ceased 
smoking (RR=1.85, 95% CI=0.70, 4.89) and less likely to have commenced smoking or 
persistently smoked with never smoked as the referent outcome (RR=0.33, 95% CI=0.13, 
0.80); similarly, the OPSMC group had a more favorable pattern of smoking behavior change 
compared with the leaflet group. 
 
Women in the high-risk group were more likely to commence or keep using calcium 
supplements (compared with never using supplements; RR=1.66, 95% CI=1.22, 2.24), and to 
report recent vitamin D supplements use (RR=1.99, 95% CI=1.27, 3.11). They were also less 
likely to report a decrease in light physical activity (RR=0.71, 95% CI=0.51, 0.99) than those 
with normal risk. There were no differences between educational intervention groups for use 
of calcium or vitamin D supplements or change in light or strenuous physical activity or 
dietary calcium intake. 
 
DISCUSSION 
Feedback of the assessment of health risks is a useful approach to improving lifestyle 
behaviors that are important to a broad spectrum of chronic diseases, but the current study is 
the first to address the important issue of whether long-term improvements can be achieved. 
In this study, after 10 years, feedback of high fracture risk was associated with a slower loss 
of FN but not LS BMD, improved use of calcium and vitamin D supplements and a favorable 
effect on smoking status. The OPSMC was associated with improved smoking behavior 
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compared with a leaflet but did not benefit BMD. These changes suggest that feedback of 
relative fracture risk based on BMD testing could be considered in young women as a 
strategy to improve long-term bone health and prevent osteoporosis in later life. 
 
Various forms of risk estimates with feedback are effective at improving informed health 
decision making, health behaviors and outcomes.2,5,19,20 For example, feedback of risk status 
to participants followed by health education is effective for improving health behaviors in the 
worksite setting, such as reducing tobacco use, alcohol consumption, and dietary fat intake.5 
However, for bone7–9,21 and other diseases, studies of such interventions have been relatively 
short-term. This is the first study to demonstrate very long-term benefits to both preventive 
behaviors and an objective health outcome (namely BMD). After an additional 10-year 
follow-up, the short-term benefits observed at 2 years for calcium supplements use and FN 
BMD persisted.7 The persistent effect of the intervention on slowing of FN BMD loss (about 
2.4%) is most important. It has been estimated that for each 5% loss in FN BMD in elderly 
women there is a 40% and 90% increase in all fractures and hip fracture risk, respectively.22 
Thus, slowing FN BMD loss by 2.4% is likely to be important for the prevention of 
osteoporosis and fracture in later life. 
 
In addition, the longer follow-up period enabled detection of effects on smoking behavior 
with the probability of women quitting smoking in the high-risk group being around double 
that of those in the normal risk group. Women in this group were also 67% less likely to 
commence or have been persistently smoking by 12 years. These are substantial effects—
they are greater than cessation rates achieved by print-based self-help interventions23 and 
telephone counseling.24 The OPSMC had similar effects on smoking. Such improvements 
have potential benefits for prevention of a wide range of diseases other than osteoporosis. 
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Smoking is the leading preventable cause of mortality including for atherosclerotic 
cardiovascular disease, lung cancer, and chronic obstructive pulmonary disease—the three 
major causes of smoking-related mortality.25 Feedback of high fracture risk was also 
associated with use of vitamin D supplementation in the long-term, doubling the probability 
of participants using a vitamin D supplement consecutively for the preceding 2 years. Given 
the high prevalence of vitamin D deficiency worldwide26 and its broad health benefits beyond 
bone,27 this behavior change has substantial public health implications. 
 
The authors observed no effect of feedback of high fracture risk on LS BMD, which is 
unsurprising as there was also no effect after 2 years.7 This could be explained by site-
specific responses of bone to lifestyle behavior changes, which have been seen with physical 
activity and calcium intake in premenopausal women. For example, an exercise protocol 
targeting the upper and lower body improved LS BMD compared with a protocol focusing on 
the lower body alone.28 In a meta-analysis of exercise trials in premenopausal women 
protocols incorporating impact loading and resistance components improved both FN and LS 
BMD, but those only with impact components improved FN BMD alone.29 The authors 
postulate that compressive forces on the spine from impact may be less than those at the hip 
and that muscle activity at the hip during jumping provides additional tensile forces not seen 
at the spine.29,30 RCTs of calcium supplements in younger women have also shown variations 
in effects at different sites, though the reasons for this are unclear.31 Nevertheless, site-
specific effects of these factors should be considered when developing future interventional 
programs. 
 
Given the lack of effect of the OPSMC on either behavior or BMD at 2 years,7 it was 
unsurprising that no effects were observed after another 10 years, although interestingly, it 
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was associated with long-term smoking behavior. As previously discussed,7 the OPSMC was 
designed similarly to a chronic disease self-management course for arthritis, which has only a 
small effect on health status and behaviors even in symptomatic populations.32,33 This study 
was in healthy women, who may be less motivated to change than those who are 
symptomatic. The lack of effect of the OPSMC for BMD and most behaviors is consistent 
with the finding that its effect on osteoporosis knowledge also dissipated from 2 years34 to 12 
years.35 
 
Limitations 
This study has several potential limitations. The 64% response rate may have resulted in 
selection bias, but as previously discussed,7 although this sample had a lower proportion of 
current smokers (17%) compared with the Tasmanian prevalence of daily smoking (29%) in 
women aged 25 to 44 years in 1998, socioeconomic factors like educational levels and the 
unemployment rate in this study approximate overall population figures. Therefore, the 
current findings are likely to be generalizable to healthy Caucasian women of this age. 
Missing data because of drop-outs is another potential limitation, but loss to follow-up was 
similar in all intervention groups, and baseline characteristics were comparable between those 
who did and did not complete the study, other than those lost to follow-up being slightly 
older. Moreover, this was accounted for by using both linear mixed-effects model and inverse 
probability weighting. The results were also similar using complete case data, so the 
likelihood of loss to follow-up influencing these findings is low. Participants could not be 
blinded to interventions, but, BMD, the most clinically important outcome, was measured 
objectively by dual-energy X-ray absorptiometry, by an operator blinded to intervention 
status and so is unlikely to be biased by subjective factors. Self-reported behavioral measures 
could be subject to recall bias, but the fact that serum 25(OH)D concentrations at 12 years 
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were substantially higher in women who reported recent vitamin D supplement supports the 
validity of self-reported data, as do previous studies validating self-reported smoking.36,37 It 
was considered unethical to perform dual-energy X-ray absorptiometry but withhold 
participants’ results so the authors are unable to compare any effects of fracture risk feedback 
to a no feedback control group. 
 
CONCLUSIONS 
Feedback of high fracture risk was associated with long-term improvements in calcium and 
vitamin D supplement use and smoking behavior, and slowed loss of FN BMD in 
premenopausal women. Such feedback could be considered as a strategy to improve long-
term bone health and prevent osteoporosis in later life. Furthermore, the improvements in 
behaviors suggest that an approach targeting bone may have benefits for other chronic 
diseases. The fact that a relatively simple behavioral intervention was able to produce such 
long-standing effects is also likely to be influential for the design of interventions for other 
chronic diseases. 
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Figure 1. Flow diagram of study population. 
 
†Unable to continue due to health related issues, including illness, pregnancy, disability and 
mortality. 
 
OPSMC, Osteoporosis Prevention and Self-management course. 
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Table 1. Characteristics of Participants by Fracture Risk Group, and by Education Intervention Group 
 Fracture risk group  Educational intervention  
Characteristics High Normal p-
value 
OPSMC Leaflet p-
value 
Baseline n=231 n=236  n=220 n=247  
Age (years), median (IQR) 38.8 (34.8, 
42.6) 
39.1 (34.6, 
42.1) 
0.70 38.6 (33.3, 
42.1) 
39.6 (35.2, 
42.3) 
0.19 
Height (cm) 162.0 (6.5) 164.2 (6.0) <0.001 162.7 (6.3) 163.5 (6.5) 0.21 
Weight (kg), median (IQR) 63.0 (57.2, 
69.0) 
71.6 (63.6, 
83.7) 
<0.001 66.8 (60.1, 
76.3) 
66.4 (60.2, 
76.0) 
0.90 
Education level, n (%)   0.97   0.22 
≤Grade 10 76 (33) 79 (34)  76 (35) 79 (32)  
Grade 10 to 12 50 (22) 49 (21)  39 (18) 60 (24)  
>Grade 12 105 (45) 106 (45)  104 (47) 107 (44)  
Employment status, n (%)   0.87   0.66 
0 hours/week 32 (14) 32 (14)  27 (12) 37 (15)  
≤20 hours/week 56 (24) 53 (22)  51 (23) 58 (24)  
> 20 hours/week 142 (62) 151 (64)  142 (65) 151 (61)  
Currently smoking, n (%) 37 (16) 42 (18) 0.61 32 (15) 47 (19) 0.20 
Ever smoked, n (%) 113 (49) 113 (48) 0.86 94 (43) 132 (54) 0.02 
Married or de facto, n (%) 167 (72) 173 (73) 0.81 169 (77) 171 (69) 0.07 
Calcium intake (mg/d), median (IQR) 720 (486, 984) 731 (534, 969) 0.58 709 (508, 986) 739 (511, 960) 0.78 
Strenuous activity level (days/2 weeks), median 
(IQR) 
3 (2, 4) 3 (2, 4) 0.51 3 (2, 4) 3 (2, 4) 0.37 
12 years n=171 n=176  n=160 n=187  
Menopause status, n (%)   0.65   0.11 
Post menopause 45 (26) 41 (23)  47 (29) 39 (21)  
Pre-menopause 65 (38) 69 (39)  61 (38) 61 (38)  
Status unclear 10 (6) 16 (9)  14 (9) 14 (9)  
Currently menopausal 51 (30) 50 (29)  38 (24) 38 (24)  
Serum 25(OH)D levels (nmol/L), median (IQR) 64.7 (51.6, 
78.9) 
60.0 (44.4, 
76.0) 
0.08 63.1 (47.6, 
78.1) 
62.7 (47.2, 
76.0) 
0.66 
23 
Fractures, n (%)a 23 (11) 20 (12) 0.56 23 (14) 20 (11) 0.30 
Notes: All values are Mean (SD) unless otherwise indicated. Boldface indicates statistical significance (p<0.05). 
aWomen reporting a fracture between baseline and 12 years. 
 
OPSMC, Osteoporosis Prevention and Self-management course; IQR, interquartile range. 
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Table 2. Absolute Change in BMD in Each Intervention Group and Effect of Fracture Risk Feedback and Educational Interventions on Absolute 
Change in BMD Between 2 and 12 Years 
 Mean of changea 
(95% CI) 
Unadjusted 
β (95% CI) 
Adjustedb 
β (95% CI) 
Bone mineral density (g/cm2)  Group by time Group by time 
Femoral neck    
Normal risk (n=162)d –0.145 (–0.159, –0.132) ref ref 
High risk (n=163)c –0.123 (–0.134, –0.112) 0.022 (0.005, 0.040) 0.023 (0.005, 0.042) 
Leaflet (n=176)d –0.130 (–0.143, –0.118) ref ref 
OPSMC (n=149)c –0.139 (–0.152, –0.127) –0.009 (–0.026, 0.009) –0.011 (–0.029, 0.008) 
Lumbar spine    
Normal risk (n=162)d –0.041 (–0.052, –0.029) ref ref 
High risk (n=163)c –0.055 (–0.066, –0.044) –0.011 (–0.027, 0.005) –0.011 (–0.027, 0.006) 
Leaflet (n=176)d –0.047 (–0.058, –0.036) ref ref 
OPSMC (n=149)c –0.048 (–0.060, –0.036) 0.001 (–0.016, 0.017) 0.002 (–0.015, 0.018) 
Notes: Boldface indicates statistical significance (p<0.05). Linear mixed-effects model was used to test treatment effect (group by time). 
aUnadjusted absolute change in BMD from 2 to 12 years within each subgroup. 
bAdjusted for other items in column, duration of follow-up, age at 2 years, change in weight and height between 2 years and 12 years and 
menopause status at 12-year. 
cIntervention group. 
dControl group. 
 
OPSMC, Osteoporosis Prevention and Self-management course; BMD, bone mineral density 
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Table 3. Effect of Fracture Risk Groups and Educational Intervention on the Change in Behaviors Between 2 and 12 Years 
Change in behaviors Fracture risk 
group 
RR (95% CI) Educational 
intervention 
RR (95% CI) 
 High Normald Unadjusted Adjusteda OPSMC Leafletd Unadjusted Adjusteda 
Smoking n=151 n=144   n=132 n=163   
Never smokedc 133 
(88) 
121 
(84.0) 
1.00 1.00 116 (88) 138 (85) 1.00 1.00 
Cessation 12 (8) 6 (4.2) 1.91 (0.74, 
4.95) 
1.85 (0.70, 
4.89) 
12 (9) 6 (4) 2.47 (0.95, 
6.40) 
2.27 (0.86, 
6.01) 
Commenced or persistent 
smoking 
6 (4) 17 (11.8) 0.34 (0.14, 
0.83) 
0.33(0.13, 
0.80) 
4 (3) 19 (12) 0.26 (0.09, 
0.75) 
0.28 (0.10, 
0.79) 
Calcium intake n=162 n=161   n=149 n=174   
Decreasedc 66 (41) 72 (45) 1.00 1.00 67 (45) 71 (41) 1.00 1.00 
Increased 96 (59) 89 (55) 0.91 (0.71, 
1.17) 
0.89 (0.69, 
1.15) 
82 (55) 103 (59) 1.10 (0.86, 
1.42) 
1.15 (0.89, 
1.48) 
Calcium supplements n=161 n=161   n=149 n=173   
Never supplementc 79 (49) 112 (70) 1.00 1.00 87 (59) 104 (60) 1.00 1.00 
Commenced or persistent 
supplement 
74 (46) 44 (27) 1.68 (1.24, 
2.28) 
1.66 (1.22, 
2.24) 
57 (38) 61 (35) 1.08 (0.81, 
1.45) 
1.12 (0.83, 
1.50) 
Cessation 8 (5) 5 (3) 1.60 (0.53, 
4.79) 
1.52 (0.50, 
4.59) 
5 (3) 8 (5) 0.73 (0.24, 
2.17) 
0.62 (0.21, 
1.87) 
Vitamin D supplementsb n=171 n=175   n=159 n=187   
No recent usec 122 
(71) 
150 (86) 1.00 1.00 119 (75) 153 (82) 1.00 1.00 
Recent use 49 (29) 25 (14) 2.01 (1.30, 
3.09) 
1.99 (1.27, 
3.11) 
40 (25) 34 (18) 1.38 (0.92, 
2.08) 
1.37 (0.90, 
2.09) 
Strenuous physical activity n=162 n=161   n=149 n=174   
Unchangedc 56 (35) 49 (30) 1.00 1.00 42 (28) 63 (36) 1.00 1.00 
Increased 43 (26) 50 (31) 0.85 (0.61, 
1.21) 
0.90 (0.62, 
1.31) 
40 (27) 53 (31) 0.88 (0.62, 
1.25) 
0.87 (0.62, 
1.24) 
Decreased 63 (39) 62 (39) 1.01 (0.77, 
1.33) 
1.02 (0.77, 
1.37) 
67 (45) 58 (33) 1.35 (1.02, 
1.78) 
1.30 (0.99, 
1.71) 
26 
Light physical activity n=161 n=161   n=148 n=174   
Unchangedc 75 (47) 64 (40) 1.00 1.00 59 (40) 80 (46) 1.00 1.00 
Increased 47 (29) 43 (27) 1.09 (0.77, 
1.55) 
1.13 (0.80, 
1.59) 
44 (30) 46 (26) 1.12 (0.79, 
1.60) 
1.07 (0.76, 
1.52) 
Decreased 39 (24) 54 (33) 0.72 (0.51, 
1.02) 
0.71 (0.51, 
0.99) 
45 (30) 48 (28) 1.10 (0.78, 
1.55) 
1.16 (0.84, 
1.61) 
Notes: Values are n (%) unless otherwise indicated. Boldface indicates statistical significance (p<0.05). Log binomial and multinomial 
regression models were used as appropriate. 
aAdjusted for age at 2 years, baseline number of children, employment status, education level, and marital status. 
bRecent use if using vitamin D supplements for the preceding 2 consecutive years and no recent use otherwise. See content for the groupings of 
all behaviors in detail. 
cReferent group for outcome. 
dReference group for comparison of intervention groups. 
 
RR, relative risk; OPSMC, Osteoporosis Prevention and Self-management course. 
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Appendix Table 1. Comparison of Baseline Characteristics of Participants Who Did and Did 
Not Complete the Study 
Characteristic Completed study Withdrawals p-value 
 n=347 n=120  
Age (years) 38.3 (5.2) 36.3 (5.6) <0.001 
Feedback of high fracture risk, n (%) 177 (51) 60 (50) 0.892 
Received OPSMC, n (%) 160 (46) 60 (50) 0.462 
Height (cm) 163.5 (6.3) 162.1 (6.6) 0.084 
Weight (kg) 69.6 (13.4) 69.3 (14.3) 0.819 
Strenuous activity level (Median) 3 3 0.345 
Calcium intake (mg/d) 782.3 (401.5) 808.6 (391.2) 0.533 
Calcium supplement use n (%) 7 (2.0) 3 (2.5) 0.414 
BMD of FN (g/cm2) 0.93 (0.13) 0.93 (0.15) 0.797 
BMD of LS (g/cm2) 1.08 (0.12) 1.08 (0.12) 0.914 
Notes: All values are mean (SD) unless otherwise indicated. 
 
OPSMC, Osteoporosis Prevention and Self-management course; BMD, bone mineral density; 
FN, femoral neck; LS, lumbar spine. 
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Appendix Table 2. Unadjusted FN and LS BMD at Each Time Point (Stratified by Fracture 
Risk Feedback Group and Educational Intervention Group) 
Time point High fracture risk Normal fracture risk  
Baseline (n=231) (n=236) 
FN BMD 0.836 (0.823, 0.850) 1.018 (1.005, 1.030) 
LS BMD 0.992 (0.982, 1.002) 1.169 (1.157, 1.181) 
2 year (n=213) (n=206) 
FN BMD 0.859 (0.848, 0.870) 1.033 (1.019, 1.046) 
LS BMD 0.994 (0.983, 1.004) 1.172 (1.158, 1.185) 
12 year (n=171) (n=176) 
FN BMD 0.736 (0.723, 0.749) 0.889 (0.873, 0.905) 
LS BMD 0.936 (0.920, 0.953) 1.130 (1.111, 1.149) 
 OPSMC Leaflet 
Baseline (n=220) (n=247) 
FN BMD 0.934 (0.915, 0.954) 0.923 (0.907, 0.938) 
LS BMD 1.084 (1.066, 1.101) 1.080 (1.065, 1.094) 
2 year (n=197) (n=222) 
FN BMD 0.945 (0.927, 0.964) 0.944 (0.928, 0.959) 
LS BMD 1.079 (1.061, 1.098) 1.083 (1.067, 1.099) 
12 year (n=160) (n=187) 
FN BMD 0.813 (0.795, 0.832) 0.814 (0.795, 0.832) 
LS BMD 1.030 (1.007, 1.054) 1.038 (1.017, 1.060) 
Notes: Values are mean (95% CI). 
 
FN, femoral neck; LS, lumbar spine; BMD, bone mineral density; OPSMC, Osteoporosis 
Prevention and Self-management course 
